Awareness, Knowledge, and Perceptions of Alopecia Among UK Postgraduate Students: A Cross-Sectional Study

In this systematic review, the authors found that hair loss in women causes significant psychological distress, with supportive interventions like cognitive behavioral therapy and cosmetic solutions helping to reduce anxiety, improve coping, and enhance quality of life.

This study reported that women with alopecia often face high out-of-pocket costs for over-the-counter treatments and camouflaging agents due to insufficient insurance coverage, which can significantly impact their financial well-being and ability to afford basic necessities.

This study found that individuals with alopecia areata in the UK, particularly women and those of Asian ethnicity with lower income and severe symptoms, spent a significant portion of their disposable income on managing the condition, highlighting wigs and private dermatology services as primary expenses.

This study found that the emotional impact of alopecia areata is significant, but it may not correlate directly with the extent of hair loss since some individuals adapt to the condition.

In this study, Alopecia Areata patients were generally knowledgeable about their condition, believed it was due to genetic or health factors, and experienced significant anxiety and depression affecting their quality of life.

This review highlights that androgenetic alopecia significantly impacts psychological well-being and quality of life, emphasizing the need for integrated psychological support alongside dermatological treatment.

This review discusses treatment options for androgenetic alopecia, highlighting the need for personalized, evidence-based approaches but reports no new clinical results.

This paper reviews various causes of alopecia in cancer patients and highlights the importance of understanding these mechanisms for effective management, but reports no new findings.

This study observed that patients with alopecia areata often have comorbidities and experience significant healthcare costs, with treatments like systemic therapies being infrequently used.

This study found that women had better knowledge and interest in androgenetic alopecia than men, especially about its definition and normal hair loss rates, but both sexes struggled with understanding its etiology and symptoms.

This review explores different types of alopecia, the effects on hair appearance and growth, and the conventional treatments available, including minoxidil and finasteride, along with their side effects and the need for future drug development and potential therapies.

This article reviews the classification, diagnosis, and management of hair disorders, emphasizing the role of trichoscopy and early diagnosis for effective treatment but reports no new clinical findings.

This review found that despite varied levels of stigmatization reported in studies, hair loss generally leads to stigmatization and a reduced quality of life, but specific research on this stigma is limited.

This study suggests that the prevalence of alopecia areata in the US remains similar to high estimates from the 1970s, with significant implications for quality of life.

This review discusses pharmacologic and non-pharmacologic treatments for androgenetic alopecia, noting that current medications like finasteride and minoxidil can slow hair loss but only partially restore hair growth, with early treatment offering better outcomes.

This study found that low-level laser therapy was the most effective non-surgical treatment for androgenetic alopecia, although the overall quality of evidence supporting various therapies was generally low.

In this community-based study, the researchers found high prevalence rates of hair loss, baldness, dandruff, and greying among men aged 18-50 in Thiruvallur district, India.

This study found that a genetic test using 5 to 20 SNPs can predict male pattern baldness with variable accuracy in European men, especially those aged 50 and older.

This review discusses emerging treatments and mechanisms for alopecia, highlighting potential therapies like janus kinase inhibitors and advances in stem-cell technology, but reports no new experimental results.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

This article examines various types of childhood alopecia and highlights the importance of identifying chronic conditions or those linked to underlying medical issues, but reports no new results.

This study found that follicular density and various hair growth ratios differ statistically between nonscarring and scarring alopecia, though significant overlap exists due to factors like sample size and scalp variation.

This study found that 58% of men aged 30-50 had androgenic alopecia, with disease severity increasing with age and many being candidates for medical treatment or hair transplantation.

This article reviews the psychosocial impacts of androgenetic alopecia on men, highlighting the importance of addressing both hair loss and associated psychological disorders for improved treatment satisfaction.